Nonoperative treatment of unicompartmental arthritis. From bracing to injection

Clinics in Sports Medicine

Volumn 33, Issue 1, 2014, Pages 1-10

  Bert, Jack M ^a   Bert, Timothy M ^b  

^a Minnesota Bone and Joint Specialists Ltd   (United States)

^b Orthopedic Clinic   (United States)

Author keywords

Knee; Nonoperative treatment; Osteoarthritis; Unicompartmental arthritis

Indexed keywords

ANALGESIC AGENT; BRADYKININ; CAPSAICIN; CELECOXIB; CHONDROITIN; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC EPOLAMINE; GLUCOSAMINE; HYALURONIC ACID; IBUPROFEN; LIDOCAINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PROTON PUMP INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; STEROID; SUBSTANCE P; TRAMADOL;

ANALGESIA; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; CARTILAGE CELL; CONSTIPATION; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DROWSINESS; EXERCISE; FATIGUE; FIBROBLAST; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; HYPERTENSION; JOINT MOBILITY; KNEE OSTEOARTHRITIS; LIVER TOXICITY; MOLECULAR WEIGHT; MUSCLE STRENGTH; NAUSEA; OBESITY; OSTEOARTHRITIS; RASH; REVIEW; SEIZURE; SEROTONIN SYNDROME; SYNOVIAL FLUID; SYNOVIOCYTE; TREATMENT PLANNING; VISCOELASTICITY; VISCOSUPPLEMENTATION; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

KNEE; NONOPERATIVE TREATMENT; OSTEOARTHRITIS; UNICOMPARTMENTAL ARTHRITIS;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; BRACES; COMBINED MODALITY THERAPY; HUMANS; OSTEOARTHRITIS, KNEE; PHYSICAL THERAPY MODALITIES; TREATMENT OUTCOME; VISCOSUPPLEMENTATION;

EID: 84888059866     PISSN: 02785919     EISSN: 1556228X     Source Type: Journal    
DOI: 10.1016/j.csm.2013.08.002     Document Type: Review

References (77)

1. Richmond J.R., Hunter D., Irrgang J., et al. AAOS clinical practice guideline summary: treatment of osteoarthritis of the knee (nonarthroplasty). JAm Acad Orthop Surg 2009, 17:591-600.
2. Briem K., Ramsey D. The role of bracing. Sports Med Arthrosc 2013, 21(1):11-17.
3. Axe J., Snyder-Mackler L., Axe M. The role of viscosupplementation. Sports Med Arthrosc 2013, 21(1):18-22.
4. Snibbe J.C., Gambardella R.A. Orthopedics 2005, 28(Suppl 2):215-220.
5. Hanypsiak B.T., Shaffer B.S. Nonoperative treatment of unicompartmental arthritis of the knee. Orthop Clin North Am 2005, 36:401-411.
6. Messier S.P., Loeser R.F., Miller G.D., et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity promotion trial. Arthritis Rheum 2004, 50(5):1501-1510.
7. Zhang W., Moskowitz R., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16(2):137-162.
8. Towheed T. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, (1). CD004257.
9. Case J.P., Baliunas A.J., Block J.A. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blinded, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 2003, 163(2):169-178.
10. Larson L. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005, 42:1364-1372.
11. Chappell C. The use of serotonin uptake inhibitors for chronic pain. Pain Practice 2011, 11:1133-1141.
12. Chappell C. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009, 146:253-260.
13. Nuesch E., et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009, 4. CD003115.
14. Goorman S.D., Watanabe T.K., Miller E.H., et al. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study. Arch Phys Med Rehabil 2008, 81:479-483.
15. Bert J.M., Gasser S.I. Approach to the osteoarthritic knee in the aging athlete: debridement to osteotomy. Arthroscopy 2002, 18:107-110.
16. Polisson R. NSAIDs: practical and therapeutic considerations in their selection. Am J Med 1996, 100:315-365.
17. Stanley K.L., Weaver J.E. Pharmacologic management of pain and inflammation in athletes. Clin Sports Med 1998, 17:375-392.
18. Rahme E., et al. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008, 103(4):872-882.
19. Barthélémy O., et al. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors. Int J Cardiol 2011, 163(3):266-271. 10.1016/j.i.jcard.2011.06.015.
20. Abramson S.B., Weaver A.I. Current state of therapy for pain and inflammation. Arthritis Res Ther 2005, 7(Suppl 4):S1-S6.
21. Solomon G. The use of COX 2 inhibitors with specific attention to use in patients requiring orthopedic surgical interventions. Orthopedic Special Edition 2002, 8:11-13.
22. Simon L.S., et al. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009, 143:238-245.
23. Altman R.D. Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care 2009, 15(Suppl 8):S236-S243.
24. Clegg D.O., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. NEngl J Med 2006, 354(8):795-808.
25. Wandel S., et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010, 341:c4675. 10.1136/bmj.c4675.
26. Bjordal J.M., et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007, 11:125-138.
27. Raynaud J.P., et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003, 48:370-377.
28. Dahmer S., Schiller R.M. Glucosamine. Am Fam Physician 2008, 78(4):471-476. 481.
29. Vignon E., Valat J.P., Rossignol M., et al. Osteoarthritis of the knee and hip and activity: a systematic international review and synthesis (OASIS). Joint Bone Spine 2006, 73:442-455.
30. Pollo F., Jackson R. Knee bracing for unicompartmental osteoarthritis. JAm Acad Orthop Surg 2006, 14:5-11.
31. Ramsey D., Russell M. Unloader braces for knee braces for knee osteoarthritis: implications on preventing progression. Sports Health 2009, 1:416-426.
32. Sharma L., Song J., Felson D., et al. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA 2001, 286:188-195.
33. Miyazaki T., Wada M., Kawahara H., et al. Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis. Ann Rheum Dis 2002, 61:617-622.
34. Hurwitz D., Ryals A., Case J., et al. The knee adduction moment during gait in subjects with knee osteoarthritis is more closely correlated with static alignment than radiographic disease severity, toe out angle and pain. JOrthop Res 2002, 20:101-107.
35. Kutzner I., Heinlein B., Graichen F., et al. Loading of the knee joint during activities of daily living measured invivo in five subjects. JBiomech 2010, 43:2164-2173.
36. D'Lima D., Steklov N., Patil S., et al. The Mark Coventry Award: invivo knee forces during recreation and exercise after knee arthroplasty. Clin Orthop Relat Res 2008, 466:2605-2611.
37. Pollo F., Otis J., Backus S., et al. Reduction of medial compartment loads with valgus bracing of the osteoarthritic knee. Am J Sports Med 2002, 30:414-421.
38. Gross K., Hillstrom H. Noninvasive devices targeting the mechanics of osteoarthritis. Rheum Dis Clin North Am 2008, 34:755-776.
39. Ramsey D., Briem K., Axe M., et al. Amechanical theory for the effectiveness of bracing for medial compartment osteoarthritis of the knee. JBone Joint Surg Am 2007, 89:2398-3407.
40. Draganich L., Reider B., Rimington T. The effectiveness of self-adjustable custom and off - the -shelf bracing in the treatment of varus gonarthrosis. JBone Joint Surg Am 2006, 88:2645-2652.
41. Kutzner I., Kuther S., Heinlein B., et al. The effect of valgus braces on medial compartment load of the knee joint-invivo load measurements in three subjects. JBiomech 2011, 44:1354-1360.
42. Fantini Pagani C., Hinrichs M., Bruggemann G. Kinetic and kinematic changes with the use of valgus knee brace and lateral wedge insoles in patients with medial knee osteoarthritis. JOrthop Res 2012, 30:1125-1132.
43. Gaasbeek R., Groen B., Hampsink B., et al. Valgus bracing in patients with medial compartment osteoarthritis of the knee: a gait analysis study of a new brace. Gait Posture 2007, 26:3-10.
44. Schmalz T., Knopf E., Drewitz H., et al. Analysis of biomechanical effectiveness of valgus-inducing knee brace for osteoarthritis of knee. JRehabil Res Dev 2010, 47:419-429.
45. Brouwer R., van Raaij T., Verhaar H., et al. Brace treatment of osteoarthritis of the knee: a prospective randomized mutli-centre trial. Osteoarthritis Cartilage 2006, 14:777-783.
46. Hewett T., Noyes F., Barber-Westin S., et al. Decrease in knee joint pain and increase in function in patients with medial compartment arthrosis: a prospective analysis of valgus bracing. Orthopedics 1998, 21:131-138.
47. Dennis A., Komistek R. An invivo analysis of the effectiveness of the osteoarthritic knee brace during heel strike and midstance of gait. Acta Chir Orthop Traumatol Cech 1999, 66:323-327.
48. Rydell N., Balazs E. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop 1971, 80:25-32.
49. Balazs E., Denlinger J. Viscosupplementation: a new concept in the treatment of osteoarthritis. JRheumatol Suppl 1993, 39:3-9.
50. Brockmeier S., Shaffer B. Viscosupplementation therapy for osteoarthritis. Sports Med Arthrosc 2006, 14:155-162.
51. Conduah A., Baker C. Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20. JPain Res 2009, 2:87-98.
52. Watterson J., Esdaile J. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. JAm Acad Orthop Surg 2000, 8:277-284.
53. Forrester J., Balazs E. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980, 40:435-446.
54. Hakansson L., Hallegran R., Venge P. Regulation of granulocyte function by hyaluronic acid: invitro and invivo effects on phagocytosis, locomotion and metabolism. JClin Invest 1980, 66:298-305.
55. Balazs E.A., Watson D., Duff I.F., et al. Hyaluronic acid in synovial fluid: I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967, 10:357-376.
56. Felson D., Lawrence R., Dieppe P., et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
57. Smith M., Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987, 7:113-122.
58. Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 1994, 12:75-82.
59. Leopold S., Warme W., Pettis P., et al. Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment. JBone Joint Surg Am 2002, 84:1619-1623.
60. Moreland L. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003, 5:54-67.
61. Gomis A., Pawlak M., Balazs E., et al. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum 2004, 50:314-326.
62. Peyron J., Balasz E. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris) 1974, 22:731-736.
63. Bellamy N., Campbell J., Robinson V., et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, (2). CD005321.
64. Bellamy N., Campbell J., Robinson V., et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, (2). CD005328.
65. Bert J., Waddell D. Viscosupplementation with hylan G-F 20 in patients with osteoarthrosis of the knee. Ther Adv Musculoskel Dis 2010, 2(3):127-132.
66. Waddell D., Bert J. The use of hyaluronan after arthroscopic surgery of the knee. Arthroscopy 2010, 26(1):105-111.
67. Hempfling H. Intra-articular hyaluronic acid after knee arthroscopy: a two-year study. Knee Surg Sports Traumatol Arthrosc 2010, 15:537-546.
68. Waddell D., Cefalu C., Bricker D. Asecond course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12 month follow-up. JKnee Surg 2005, 18(1):7-15.
69. Raynaud J. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 2005, 13:111-119.
70. Burns W., Bourne R., Chesworth B., et al. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res 2006, 446:29-33.
71. Waddell D., Bricker D. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. JManag Care Pharm 2007, 13:113-121.
72. Wang Y., Hall S., Hanna F., et al. Effects of hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two year single-blind clinical trial. BMC Musculoskelet Disord 2011, 12:195-203.
73. Strauss E., Schachter A., Frenkel S., et al. The efficacy of intra-articular hyaluronan injection after microfracture technique for the treatment of articular cartilage lesions. Am J Sports Med 2009, 37:720-726.
74. Tytherleigh-Strong G., Hurtig M., Miniaci A. Intra-articular hyaluron following autogenous osteochondral grafting of the knee. Arthroscopy 2005, 21:999-1005.
75. Bannuru R.R., Natov N.S., Obadan I.E., et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009, 61:1704-1711.
76. Wang C., Lin J., Chang C., et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. JBone Joint Surg Am 2004, 86:538-545.
77. Zhang W., Nuki G., Moskowitz R.W., et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III. Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010, 18:476-499.